Advanced gastric cancer associated with DIC successfully treated with 5-FU and cisplatin: A case report

被引:0
|
作者
Matsumoto, S
Kiba, T
Numata, K
Ihata, Y
Morita, K
Kitamura, T
Saito, S
Nakatani, Y
Tanaka, K
Sekihara, H
机构
[1] Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Div Anatom & Surg Pathol, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Med Ctr, Dept Internal Med, Gastroenterol Ctr, Yokohama, Kanagawa, Japan
关键词
advanced gastric cancer; DIC; poorly differentiated adenocarcinoma; chemotherapy; FP therapy;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report a case of advanced gastric cancer complicated by disseminated intravascular coagulation successfully treated with chemotherapy consisting of 5-fluorouracil and cisplatin. The patient was a 53-year-old woman who complained of loss of appetite, weight loss, and low back pain. Based on the laboratory data, a diagnosis of disseminated intravascular coagulation was made. Gastroscopy revealed gastric carcinoma (Borrmann type 3) that was continuously bleeding, and chest computed tomography showed a solitary lung metastasis and bilateral pleural effusion. Bone scintigraphy revealed multiple bone metastases. Accordingly, we made a diagnosis of stage IV gastric cancer complicated by disseminated intravascular coagulation. We selected the 5-fluorouracil and cisplatin combination chemotherapy for treatment and obtained the patient's consent. After two cycles of the 5-fluorouracil and cisplatin therapy, the bleeding symptoms improved and the disseminated intravascular coagulation process was successfully controlled. We concluded that disseminated intravascular coagulation caused by gastric cancer may be improved when the primary cancer and its metastases are brought under control by treatment with FP combination chemotherapy.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 50 条
  • [11] Effect of the multiple modulation 5-FU in advanced gastric cancer
    Kuznetsova, EA
    Garin, AM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S14 - S14
  • [12] Phase I Irinotecan, Cisplatin and protracted infusion 5-FU (ICF) in advanced gastric cancer (AGC)
    Fernandez Martos, Carlos
    Segura, Angel
    Aparicio, Jorge
    Molins, Carmen
    Busquier, Isabel
    Poveda, Andres
    Balcells, Miquel
    ANNALS OF ONCOLOGY, 2004, 15 : 238 - 238
  • [13] Phase II study of paclitaxel, cisplatin, and 5-FU combination chemotherapy in patients with advanced gastric cancer
    Cho, S.
    Shim, H.
    Lee, S.
    Ahn, J.
    Yang, D.
    Kim, Y.
    Park, C.
    Lee, J.
    Chung, I.
    Kim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [14] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WOOLLEY, P
    SMITH, F
    ESTEVEZ, R
    GISSELBRECHT, C
    ALVAREZ, C
    BOIRON, M
    MACHADO, C
    LAGARDE, C
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 455 - 455
  • [15] A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
    Ducreux, M
    Rougier, P
    Pignon, JP
    Douillard, JY
    Seitz, JF
    Bugat, R
    Bosset, JF
    Merouche, Y
    Raoul, JL
    Ychou, M
    Adenis, A
    Berthault-Cvitkovic, F
    Luboinski, M
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1185 - 1191
  • [16] ADVANCED GASTRIC-CANCER SUCCESSFULLY RESECTED FOLLOWING CISPLATIN THERAPY - REPORT OF A CASE
    SAJI, S
    KISHIMOTO, Y
    SAKATA, K
    FURUTA, T
    TANEMURA, H
    KAWATA, R
    JOURNAL OF SURGICAL ONCOLOGY, 1987, 36 (02) : 138 - 141
  • [17] A case of advanced gastric cancer treated successfully with nivolumab
    Kawada, Junji
    Tamura, Shigeyuki
    Sasaki, Yo
    ANNALS OF ONCOLOGY, 2022, 33 : S529 - S529
  • [18] The clinical studies of weekly Taxol plus Cisplatin and continuous infusion of 5-FU in patients with advanced gastric cancer
    Jia, Chen
    Ling, Hang F.
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [19] Predictive value of genomic polymorphisms on clinical outcome to cisplatin/5-FU chemotherapy in patients with advanced gastric cancer
    Goekkurt, Eray
    Wittmer, Corinna
    Wolschke, Christine
    Stueber, Christian
    Hoehn, Stephan
    Laack, Eckart
    Erbersdobler, Andreas
    Hossfeld, Dieter K.
    Stoehlmacher, Jan
    ANNALS OF ONCOLOGY, 2004, 15 : 237 - 238
  • [20] Economic assessment of capecitabinexisplatin versus 5-FU/Cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain
    Darba, J.
    Restovic, G.
    De Arellano, Ramirez A.
    ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50